logo
episode-header-image
May 21
20m 12s

Ozempic Is a Hit. So Why Is the Drugmake...

THE WALL STREET JOURNAL & GIMLET
About this episode
Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica Mendoza hosts.  Further Listening: Trillion Dollar Shot  Why WeightWatche ... Show More
Up next
Yesterday
The Healthcare Costs of Trump’s Big Beautiful Bill
President Trump’s megabill cuts over $1 trillion in healthcare spending over the next decade, mainly from Medicaid. Experts project nearly 8.7 million fewer people covered by Medicaid, and hospitals face reduced payments and higher costs. WSJ’s Dominique Mosbergen reports on the ... Show More
20m 47s
Jul 8
Why Trump Pushed His Tariff Deadline
When President Trump paused most of his “Liberation Day” tariffs for 90 days last spring, the administration had hoped to cut dozens of trade deals. As trade advisor Peter Navarro put it, there could be "90 deals in 90 days." But as Trump’s deal deadline approached, it became cle ... Show More
19m 3s
Jul 7
AI Is Coming for Entry-Level Jobs
Artificial intelligence is shaking up business in a big way, and recent college graduates are feeling the pinch. WSJ’s Chip Cutter explores the new corporate philosophy emerging around hiring and explains how the promise of artificial intelligence is putting entry-level jobs on t ... Show More
19m 11s
Recommended Episodes
Apr 19
What’s News in Markets: Lilly Surges, UnitedHealth Plummets, Netflix Aims for $1 Trillion
Why did news from a weight-loss drug pill trial boost Eli Lilly? And how are costs in the Medicare business affecting UnitedHealth? Plus, what ambitious goals has Netflix set for itself? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove ... Show More
5m 13s
Oct 2024
U.S. Stocks End the Week Higher
Plus: Netflix shares hit a record high following its most profitable quarter ever. And CVS Health fell after the healthcare giant replaced its CEO and warned on earnings. Plus, french fry producer Lamb Weston’s shares soar. Danny Lewis hosts. Sign up for the WSJ's free What's New ... Show More
2m 45s
Oct 2024
What’s News in Markets: United Soars, CVS Warns, Netflix Shines
How did rivals help United take off? And what has investors worried about the health of CVS? Plus, why Netflix shares jumped. Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Lea ... Show More
5m 27s
Jul 2024
Dow Falls More Than 500 Points
Plus: Shares of Eli Lilly and Novo Nordisk decline as competition in the anti-obesity drug market ramps up. After the bell, Netflix reported stronger revenue, but said subscriber growth in the current quarter will be weaker than a year ago. J.R. Whalen reports. Sign up for the WS ... Show More
2m 37s
Sep 2024
Nike CEO Abruptly Steps Down After Struggling Sales & 23andMe in Turmoil
Episode 414: Neal and Toby break down with Nike CEO John Donahoe announces he is retiring after the company's struggling sales. Plus, the guys explain why every single board member resigned from 23andMe this week. Then, Olive Garden cuts a deal with Uber to deliver bread sticks a ... Show More
30m 31s
Apr 29
SOTS 2nd Hour: Tariff Updates, Earnings Wrap-up, and Is This Rally Real? – plus: Coca-Cola CEO Talks Results 4/29/25
Fresh news on the tariff front when it comes to potential deals – and hopes of relief for the automakers… Carl Quintanilla, Sara Eisen, and David Faber broke down the latest from the White House, alongside the morning’s biggest earnings stories: from GM pulling guidance and delay ... Show More
42m 32s
Nov 2024
What’s News in Markets: Tesla Seesaw, Pharma Selloff, Streaming Shines
How has Elon Musk’s deepening relationship with President-elect Donald Trump affected Tesla stock? And why did Big Pharma stocks sell off? Plus, what did Disney and Spotify have to say about trends in streaming? Host Francesca Fontana discusses the biggest stock moves of the week ... Show More
5m 48s
Sep 2024
Making Sense of Nvidia’s Record Drop
A.M. Edition for Sep. 4. WSJ finance editor Alex Frangos tells us where investors are looking for clues on where the U.S. economy is headed and discusses Nvidia’s outsize influence on markets after yesterday’s selloff. Plus, the killing of an American-Israeli hostage in Gaza brin ... Show More
13m 32s
Jan 2025
U.S. Indexes Trim Gains After Strong Week
Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports. Sign ... Show More
2m 32s
Listen to millions of songs and podcasts on Anghami